Total trials
343
Active
67
Phase 3
5
Total enrollment
110,783
Pipeline matrix
Showing 6 of 6 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Serogroup B meningococal vaccine | — | — | — | — | — | 1 | |
| VE818 | — | — | — | — | — | 1 | |
| Oral Vancomycin | — | — | — | — | — | 1 | |
| Blood sample | — | — | — | — | — | 1 | |
| H1 blockade: Telfast: 180mg Fexofenadine | — | — | — | — | — | 1 | |
| Baxter therapy | — | — | — | — | — | 1 |
Next readouts
- 2026-04
- 2026-07-07
- 2026-07-31
- 2026-12-31
- 2027-12-31
Top conditions
- Suicidal Ideation15
- Healthy11
- Suicide10
- Suicide Prevention10
- Physical Activity9
- Neck Pain9
- Pressure Ulcer9
- Developmental Coordination Disorder6
Frequently asked questions about University Ghent
- How many clinical trials does University Ghent have on ClinicalTrials.gov?
- University Ghent is listed as the lead sponsor on 343 clinical trials in ClinicalTrials.gov, 67 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University Ghent's trials are in Phase 3?
- 5 of University Ghent's trials are in Phase 3, spread across 6 active drug programs.
- What therapeutic areas does University Ghent focus on?
- University Ghent's most-studied conditions on ClinicalTrials.gov are Suicidal Ideation, Healthy, Suicide, Suicide Prevention, Physical Activity.
- When are University Ghent's next clinical trial readouts?
- University Ghent has 5 upcoming primary-completion readouts tracked here; the soonest is “Different Treatments in Chronic Pain Patients.”, expected around 2026-04.